Loading...
CD38-Directed Therapies for Management of Multiple Myeloma
The survival outcomes for multiple myeloma have improved several-fold in the past two decades, primarily due to the introduction of therapies with novel mechanisms of action including immunomodulatory agents, proteasome inhibitors, stem cell transplant and monoclonal antibodies in the schema of ther...
Saved in:
| Published in: | Immunotargets Ther |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8254545/ https://ncbi.nlm.nih.gov/pubmed/34235096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S259122 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|